Sectoral Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Sectoral Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-21,899	Closed	-$1.94M	–	92
2015 Q4	$1.94M	Sell	21,899 -6,253	-22%	-$494K	0.08%	64
2015 Q3	$2.08M	Sell	28,152 -17	-0.1%	-$1.41K	0.1%	59
2015 Q2	$2.28M	Buy	28,169 +6,046	+27%	+$394K	0.1%	59
2015 Q1	$927K	Buy	+22,123	New	+$628K	0.04%	73

Other funds holding EGRX

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Sectoral Asset Management's EGRX Position: Q1 2016 in Review

Sectoral Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2016, closing a stake of 21,899 shares — an estimated $1.94M sold.

Sectoral Asset Management first reported a position in EGRX in Q1 2015 and held it in 4 quarters. The position peaked at $2.28M in Q2 2015. 119 funds tracked by Wall St. Rank hold EGRX as of Q1 2016.

Sectoral Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Sectoral Asset Management sold 21,899 Eagle Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.94M.
Sectoral Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
Sectoral Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $2.28M in Q2 2015.
119 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2016.

Based on Sectoral Asset Management's 13F filing for Q1 2016, filed 13 May 2016.